---
title: "MapLight Therapeutics, Inc. (MPLT.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/MPLT.US.md"
symbol: "MPLT.US"
name: "MapLight Therapeutics, Inc."
industry: "Biotechnology"
---

# MapLight Therapeutics, Inc. (MPLT.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.maplightrx.com](https://www.maplightrx.com) |

## Company Profile

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company’s products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and A...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -7.64 | 423/603 | - | - | - |
| PB | -2.86 | 501/603 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-15T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 75% |
| Overweight | 1 | 25% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 17.31 |
| Highest Target | 34.00 |
| Lowest Target | 28.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/MPLT.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/MPLT.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/MPLT.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.